<DOC>
	<DOC>NCT00705042</DOC>
	<brief_summary>The purpose of this study is to evaluate the Pharmacokinetics (PK) and safety and tolerability of etanercept, 25 and 50 mg, administered as a single dose to healthy male Chinese subjects.</brief_summary>
	<brief_title>Study Evaluating Enbrel Drug Levels in Healthy Male Chinese Subjects</brief_title>
	<detailed_description />
	<mesh_term>Etanercept</mesh_term>
	<criteria>Healthy male Chinese subjects, ages 18 to 45. BMI in the range of 18 to 30 kg/m2 and weight greater than or equal to 50 kg. Active tuberculosis (TB) or history of TB. Serious infection (associated with hospitalization and/or antibiotics) within 1 month before study drug administration. History of protein drug hypersensitivity.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2009</verification_date>
</DOC>